| | | MPEG10-AMINE
CAS:1383658-09-0
Formula: C21H45NO10
GëÑ95%
BADC-00938
m-PEG10-amine; mPEG10-NH2; 2,5,8,11,14,17,20,23,26,29-decaoxahentriacontan-31-amine; 3,6,9,12,15,18,21,24,27,30-Decaoxahentriacontan-1-amine mPEG10-bromide
Formula: C21H43BrO10
>95%
BPG-3577
m-PEG10-Br; Bromo-PEG10-methoxy; 31-Bromo-2,5,8,11,14,17,20,23,26,29-decaoxahentriacontane; 2,5,8,11,14,17,20,23,26,29-Decaoxahentriacontane, 31-bromo-; Methyl-PEG10-bromide MPEG11-AMINE
CAS:854601-60-8
Formula: C23H49NO11
GëÑ95%
BADC-01167
m-PEG11-amine; mPEG11-NH2; 2,5,8,11,14,17,20,23,26,29,32-Undecaoxatetratriacontan-34-amine; 3,6,9,12,15,18,21,24,27,30,33-Undecaoxatetratriacontan-1-amine mPEG11-bromide
CAS:1258596-39-2
Formula: C23H47BrO11
>95%
BP-501678
m-PEG11-Br; Bromo-PEG11-methoxy; 34-Bromo-2,5,8,11,14,17,20,23,26,29,32-undecaoxatetratriacontane; 2,5,8,11,14,17,20,23,26,29,32-Undecaoxatetratriacontane, 34-bromo- mPEG12-bromide
CAS:1620461-89-3
Formula: C25H51BrO12
>95%
BPG-2418
m-PEG12-Br; m-PEG12-bromide; 2,5,8,11,14,17,20,23,26,29,32,35-Dodecaoxaheptatriacontane, 37-bromo-; Br-(CH2CH2O)12-Me; Bromo-PEG12-methoxy; 37-Bromo-2,5,8,11,14,17,20,23,26,29,32,35-dodecaoxaheptatriacontane mPEG16-alcohol
CAS:133604-58-7
Formula: CGéâGéâHGéåGéêOGéüGéç
>95%
BP-501022
mPEG16-OH; 2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47-Hexadecaoxanonatetracontan-49-ol MPEG16-AMINE
CAS:907577-50-8
Formula: CGéâGéâHGéåGéëNOGéüGéå
>95%
BP-501667
mPEG16-NH2; 2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47-Hexadecaoxanonatetracontan-49-amine mPEG16-thiol
CAS:874820-38-9
Formula: C33H68O16S
>95%
BPG-2519
mPEG16-SH; 2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47-Hexadecaoxanonatetracontane-49-thiol MPEG36-CH2CH2COONHS ESTER
Formula: C80H155NO41
>95%
BPG-2683
m-PEG37-NHS ester; mPEG36-CH2CH2COONHS Ester; SCHEMBL17746967; mPEG36-OCH2CH2COONHS Ester; AKOS030213580; GS-9500; BP-22248; 2,5-Dioxopyrrolidin-1-yl 2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62,65,68,71,74,77,80,83,86,89,92, MPEG4-AMINE
CAS:85030-56-4
Formula: C9H21NO4
GëÑ95%
BADC-01166
m-PEG4-amine; 3,6,9,12-Tetraoxatridecylamine; 2,5,8,11-Tetraoxatridecan-13-amine; mPEG4-NH2; 3,6,9,12-Tetraoxatridecanamine; Methyl-PEG4-Amine; Triethylene glycol 2-aminoethyl methyl ether; 3,6,9,12-Tetraoxatridecane-1-amine mPEG6-acid
CAS:1347750-72-4
Formula: C14H28O8
GëÑ95%
BP-501242
m-PEG6-COOH; m-PEG6-acid; 2,5,8,11,14,17-Hexaoxa-20-icosanoic Acid; m-PEG5-CH2CH2COOH; mPEG5-propionic acid; 2,5,8,11,14,17-hexaoxaicosan-20-oic acid; 4,7,10,13,16,19-Hexaoxaeicosanoic acid MPEG6-AMINE
CAS:184357-46-8
Formula: C13H29NO6
GëÑ95%
BADC-01011
m-PEG6-amine; 2,5,8,11,14,17-Hexaoxanonadecan-19-amine; mPEG6-NH2; 1-amino-3,6,9,12,15,18-hexaoxanonadecane; 3,6,9,12,15,18-Hexaoxanonadecan-1-amine; Methyl-PEG6-amine; H2N-(CH2CH2O)6-Me mPEG6-bromide
CAS:125562-29-0
Formula: C13H27BrO6
>96%
BP-501598
m-PEG6-Br; m-PEG6-bromide; Bromo-PEG6-methoxy; 19-bromo-2,5,8,11,14,17-hexaoxanonadecane; Methyl-PEG6-bromide; 2,5,8,11,14,17-Hexaoxanonadecane, 19-bromo-; 1-bromo-2-[2-(2-{2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-ethane; Br- MPEG7-AMINE
CAS:170572-38-0
Formula: C15H33NO7
GëÑ95%
BADC-00986
m-PEG7-amine; 2,5,8,11,14,17,20-Heptaoxadocosan-22-amine; mPEG7-NH2; 3,6,9,12,15,18,21-heptaoxadocosylamine; Methyl-PEG7-amine; alpha-Methoxy-omega-amino hepta(ethylene glycol); 3,6,9,12,15,18,21-Heptaoxadocosane-1-amine; H2N-(CH2CH2O)7-Me mPEG7-bromide
CAS:104518-25-4
Formula: C15H31BrO7
>96%
BP-501654
m-PEG7-Br; 22-Bromo-2,5,8,11,14,17,20-heptaoxadocosane; Bromo-PEG7-methoxy; m-PEG7-bromide; 2,5,8,11,14,17,20-Heptaoxadocosane, 22-bromo-; 1-bromo-2-(2-(2-(2-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethane; Methoxy hepta(et MPEG8-AMINE
CAS:869718-81-0
Formula: C17H37NO8
GëÑ95%
BADC-01177
m-PEG8-amine; 2,5,8,11,14,17,20,23-Octaoxapentacosan-25-amine; mPEG8-NH2; 3,6,9,12,15,18,21,24-Octaoxapentacosan-1-amine; 3,6,9,12,15,18,21,24-octaoxa-pentacosylamine; methyl-PEG8-amine mPEG8-bromide
CAS:1056881-04-9
Formula: C17H35BrO8
>95%
BP-500383
m-PEG8-Br; m-PEG8-bromide; Bromo-PEG8-methoxy; 25-bromo-2,5,8,11,14,17,20,23-octaoxapentacosane; 2,5,8,11,14,17,20,23-Octaoxapentacosane, 25-bromo- mPEG9-bromide
CAS:125562-30-3
Formula: C19H39BrO9
>95%
BP-500717
m-PEG9-Br; m-PEG9-bromide; 28-bromo-2,5,8,11,14,17,20,23,26-nonaoxaoctacosane; Bromo-PEG9-methoxy; 2,5,8,11,14,17,20,23,26-Nonaoxaoctacosane, 28-bromo-; Methyl-peg9-bromide MPEG9-CH2CH2COONHS ESTER
Formula: C26H47NO14
>97%
BPG-2395
m-PEG10-NHS ester; Methyl-PEG10-NHS Ester; 2490419-63-9; mPEG9-CH2CH2COONHS Ester; 2,5-dioxopyrrolidin-1-yl 2,5,8,11,14,17,20,23,26,29-decaoxadotriacontan-32-oate; SCHEMBL22444953; MFCD31654038; AKOS040743424 MRK 016
CAS:783331-24-8
Formula: C17H20N8O2
>98%
783331-24-8
MRK-016; MRK016; 3-(1,1-Dimethylethyl)-7-(5-methyl-3-isoxazolyl)-2-[(1-methyl-1H-1,2,4-triazol-5-yl)methoxy]-pyrazolo[1,5-d][1,2,4]triazine; 3-(9-(tert-Butyl)-8-((1-methyl-1H-1,2,4-triazol-5-yl)methoxy)pyrazolo[1,5-d][1,2,4]triazin-2-yl)-5- MS645
CAS:2250091-96-2
Formula: C48H54Cl2N10O2S2
GëÑ98%
2250091-96-2
N,N'-1,10-Decanediylbis{2-[(6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]acetamide}; 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, N,N'-1,10-decanediylbis[4-(4-chlorophe MT1
CAS:2060573-82-0
Formula: C54H66Cl2N10O9S2
GëÑ98%
2060573-82-0
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, N,N'-3,6,9,12,15,18,21-heptaoxatricosane-1,23-diylbis[4-(4-chlorophenyl)-2,3,9-trimethyl-, (6S,6'S)-; MT1 BET inhibitor; N,N'-3,6,9,12,15,18,21-Heptaoxatricosane-1,23-diylbis MUDANPIOSIDE C
CAS:172760-03-1
Formula: C30H32O13
>98%
NP4526
((2R,3S,4S,5R,6S)-6-(((1aR,1a1S,2R,3aR,5S,5aR)-1a1-((benzoyloxy)methyl)-2-hydroxy-5-methyltetrahydro-1H-3,4-dioxa-2,5-methanocyclobuta[cd]pentalen-5a(5H)-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methyl 4-hydroxybenzoate. MULBERROFURAN G
CAS:87085-00-5
Formula: C34H26O8
> 95%
NP4658
Mulberrofuran G|87085-00-5|Albanol A|1-(2,4-Dihydroxyphenyl)-17-(6-hydroxy-1-benzofuran-2-yl)-11-methyl-2,20-dioxapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-3(8),4,6,11,14,16,18-heptaene-5,15-diol|NSC649229|iso-mulbel-rochromene|NSC 64922 MULBERROFURAN G PENTAACETATE
CAS:99217-75-1
Formula: C44H36O13
> 95%
NP4673
(3aR,8aS,13bR,13cS)-6-(6-Acetoxy-1-benzofuran-2-yl)-8a-(2,4-diacetoxyphenyl)-2-methyl-1,8a,13b,13c-tetrahydro-3aH-benzo[3,4]isochromeno[1,8-bc]chromene-4,11-diyl diacetate MULBERROFURAN Q
CAS:101383-35-1
Formula: C34H24O10
>98%
B0005-053485
4-(2,4-dihydroxyphenyl)-10,18-dihydroxy-8-(6-hydroxy-1-benzofuran-2-yl)-14-methyl-3,5,15-trioxahexacyclo[12.7.1.0;{2,4}.0;{2,12}.0;{6,11}.0;{16,21}]docosa-6,8,10,16,18,20-hexaen-13-one MULTIFLORENOL
CAS:2270-62-4
Formula: C30H50O
GëÑ95% by HPLC
BBF-05174
26-Norolean-7-en-3-ol, 13-methyl-, (3+¦,13+¦,14+¦)-; (3+¦)-D:C-Friedoolean-7-en-3-ol; (14+¦)-13+¦-methyl-26-norolean-7-en-3+¦-ol; 26-Norolean-7-en-3-ol, 13-methyl-, (3beta,13alpha,14beta)-; (3S,4aR,6aS,6bS,8aR,12aR,14aR,14bR)-4,4,6a,6b,8a,11,11,14 MUPIROCIN CALCIUM EP IMPURITY E SODIUM SALT
CAS:116182-44-6
Formula: C26H43NaO9
95%
116182-44-6
[2R-[2+¦(1S*,2S*),3+¦,4a+¦,7+¦(E),8+¦,8a+¦]]-9-[[4-[hexahydro-3,8-dihydroxy-2-(2-hydroxy-1-methylpropyl)-2H,5H-pyrano[4,3-b]pyran-7-yl]-3-methyl-1-oxo-2-butenyl]oxy]nonanoic Acid Monosodium Salt; 2H,5H-Pyrano[4,3-b]pyranyl Mupirocin Sodium Impuri MUPIROCIN EP IMPURITY B
CAS:71980-98-8
Formula: C26H44O8
> 95%
71980-98-8
Pseudomonic Acid C; (2E)-5,9-Anhydro-2,3,4,8-tetradeoxy-8-(5-hydroxy-4-methyl-2-hexen-1-yl)-3-methyl-L-talo-Non-2-enonic Acid 8-Carboxyoctyl Ester; 9-[[(2E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[(2E,4R,5S)-5-hydroxy-4-methylhex-2-enyl]tetrahydr MUPIROCIN EP IMPURITY E
CAS:71087-96-2
Formula: C26H44O9
95%
71087-96-2
Mupirocin pyranyl analog; Mupirocin impurity 2; Nonanoic acid, 9-(((2E)-4-((2R,3S,4aS,7S,8S,8aR)-hexahydro-3,8-dihydroxy-2-((1S,2S)-2-hydroxy-1-methylpropyl)-2H,5H-pyrano(4,3-b)pyran-7-yl)-3-methyl-1-oxo-2-buten-1-yl)oxy)-; 9-[[(2E)-4-[(2R, MUPIROCIN LITHIUM
CAS:73346-79-9
Formula: C26H43LiO9
GëÑ95.0%
BBF-04554
L-talo-Non-2-enonic acid, 5,9-anhydro-2,3,4,8-tetradeoxy-8-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methylpropyl]oxiranyl]methyl]-3-methyl-, 8-carboxyoctyl ester, lithium salt, (2E)-; L-talo-Non-2-enonic acid, 5,9-anhydro-2,3,4,8-tetradeoxy-8-[[3-( MURISTERONE A
CAS:38778-30-2
Formula: C27H44O8
GëÑ97% by HPLC
38778-30-2
(2+¦,3+¦,5+¦,11+¦,22R)-2,3,5,11,14,20,22-Heptahydroxycholest-7-en-6-one; Mur A MUSETTAMYCIN
CAS:63710-09-8
Formula: C36H45NO14
BBF-02300
Mus; Antibiotic MA 144S2; 1-Hydroxy MA144 S1; NSC 219941; 1-Naphthacenecarboxylic acid,2,3,4,6,11-hexahydro-2,5,7,10-tetrahydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-L-lyxo-hexo MUSK KETONE
CAS:81-14-1
Formula: C14H18N2O5
GëÑ95%
81-14-1
Ethanone, 1-[4-(1,1-dimethylethyl)-2,6-dimethyl-3,5-dinitrophenyl]-; 1-[4-(1,1-Dimethylethyl)-2,6-dimethyl-3,5-dinitrophenyl]ethanone; Acetophenone, 4'-tert-butyl-2',6'-dimethyl-3',5'-dinitro-; 1-(4-(tert-Butyl)-2,6-dimethyl-3,5-dinitrophen MUTILIN
CAS:6040-37-5
Formula: C20H32O3
>99% by HPLC
BBF-04273
[3aS-(3a+¦,4+¦,5+¦,6+¦,8+¦,9+¦,9a+¦,10S*)]-6-Ethenyloctahydro-5,8-dihydroxy-4,6,9,10-tetramethyl-3a,9-propano-3aH-cyclopentacycloocten-1(4H)-one; (+)-Mutilin; (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-Ethenyloctahydro-5,8-dihydroxy-4,6,9,10-tetramethyl-3a,9- MYCOTHIONE
CAS:669091-43-4
Formula: C34H58N4O24S2
669091-43-4
2',2'''-[Dithiobis[[(2R)-2-(acetylamino)-1-oxo-3,1-propanediyl]imino]]bis[1-O-(2-deoxy-+¦-D-glucopyranosyl)-D-myo-inositol]; (2R,2'R)-3,3'-Disulfanediylbis(2-acetamido-N-((2R,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-(((1S,2R,3R,4S,5S,6 MYCOTRIENOL I
CAS:81904-15-6
Formula: C26H33NO6
BBF-01976
Ansatrienol A; (4E,6S,7S,8R,10E,12E,14E,16R)-6,8-dihydroxy-16-methoxy-5,7-dimethyl-19-azabicyclo[18.3.1]tetracosa-1(23),4,10,12,14,20-hexaene-18,22,24-trione MYCOVERSILIN
CAS:88527-18-8
Formula: C18H16O8
BBF-01978
8,11-Dimethylpyrano(3,2-a)xanthene-1,5,6,9,10,12-hexol; Pyrano(3,2-a)xanthene-1,5,6,9,10,12-hexol, 8,11-dimethyl- myo-Inositol 1,3,4,5,6-pentaphosphate
CAS:20298-95-7
Formula: C6H17O21P5
20298-95-7
InsP5; myo-Inositol, 1,3,4,5,6-pentakis(dihydrogen phosphate); Inositol, 1,3,4,5,6-pentakis(dihydrogen phosphate), myo-; Inositol 1,3,4,5,6-pentakisphosphate; Inositol 1,3,4,5,6-pentaphosphate; Inositol pentaphosphate; Ins(1,3,4,5,6)P5; myo MYO-INOSITOL TRISPYROPHOSPHATE HEXASODIUM SALT
CAS:23103-35-7
Formula: C6H6Na6O21P6
23103-35-7
ITPP hexasodium salt; myo-Inositol, cyclic 1,2:3,4:5,6-tris(P,P'-dihydrogen diphosphate), sodium salt (1:6); Inositol, cyclic 1,2:3,4:5,6-tris(dihydrogen pyrophosphate), hexasodium salt, myo-; myo-Inositol, cyclic 1,2:3,4:5,6-tris(P,P'-dihy myo-Inositol-[1,2,3,4,5,6-d6]
CAS:68922-44-1
Formula: C6H6D6O6
98% by CP; 98% atom D
BLP-001057
myo-Inositol-1,2,3,4,5,6-d6; (2H6)Cyclohexane-1,2,3,4,5,6-hexol; myo-Inositol-C-d6; Cyclohexitol-d6; Dambose-d6; Inosital-d6; Inosite-d6; Inositene-d6; Inositina-d6; Inositol-d6; Mesoinosite-d6; Mesoinositol-d6; Mesol-d6; Mesovit-d6; Myoino MYRIANTHIC ACID 3,23-ACETONIDE
CAS:578710-52-8
Formula: C33H52O6
98.0%
NP7064
Myrianthic acid 3,23-acetonide; 578710-52-8; (1R,2R,4R,5S,10R,11R,14R,15S,18S,21R,22R,23S)-4,22-dihydroxy-2,7,7,10,14,15,21,22-octamethyl-6,8-dioxahexacyclo[12.12.0.02,11.05,10.015,24.018,23]hexacos-24-ene-18-carboxylic acid MYRICADIOL
CAS:17884-88-7
Formula: C30H50O2
98.5%
NP6631
D-Friedoolean-14-ene-3+¦,28-diol; (3S,4aR,6aR,6aS,8aS,12aS,14aR,14bR)-8a-(hydroxymethyl)-4,4,6a,6a,11,11,14b-heptamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-ol MYRICANANIN A
CAS:1079941-35-7
Formula: C20H24O5
> 95%
NP4670
(8S,9S)-16-Methoxytricyclo[12.3.1.12,6]nonadeca-1(18),2(19),3,5,14,16-hexaene-3,8,9,17-tetrol MYRICERIC ACID B
CAS:55497-79-5
Formula: C17H19NaO6
96%
NP6624
Myriceric acid B;55497-79-5;(4aS,6aR,6aR,6bR,8aR,10S,12aR,14bS)-6a-[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxymethyl]-10-hydroxy-2,2,6b,9,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid;HY-N322 MYRICERIC ACID C
CAS:162059-94-1
Formula: C48H60O10
96%
NP6843
(4aS,6aR,6aR,6bR,8aR,12aR,14bS)-10-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-6a-[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxymethyl]-2,2,6b,9,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid MYRICETIN-[2,3,4-13C3]
Formula: C12[13C]3H10O8
98% by CP; 99% atom 13C
BLP-009490
Myricetol-2,3,4-13C3; 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one-2,3,4-13C3; Cannabiscetin-2,3,4-13C3 MYRISTIC ACID-13,13,14,14,14-[D5]
CAS:327077-03-2
Formula: C14H23D5O2
98% by CP; 98% atom D
BLP-001693
Myristic Acid (13,13,14,14,14-D5); Tetradecanoic acid-13,13,14,14,14-d5; Tetradecanoic Acid-d5; 1-Tetradecanoic Acid-d5; 1-Tridecanecarboxylic Acid-d5; NSC 5028-d5; n-Tetradecan-1-oic Acid-d5; n-Tetradecanoic Acid-d5; n-Tetradecoic Acid-d5 MYTOXIN B
CAS:105049-15-8
Formula: C29H36O9
GëÑ95%
BADC-00809
mytoxin B; 105049-15-8; (1'Z,2S,6'R,11'R,13'R,15'S,16'R,19'Z,23'R,27'R)-23'-acetyl-27'-hydroxy-9',15'-dimethyl-4',12',17',24'-tetraoxaspiro[oxirane-2,14'-pentacyclo[21.3.1.1,.0,.0,octacosane]-1',9',19'-triene-3',18'-dione MZ2
CAS:1797406-70-2
Formula: C51H64ClN9O9S2
1797406-70-2
MZ 2; MZ-2; (2S,4R)-1-((S)-2-(tert-butyl)-20-((S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-4,19-dioxo-6,9,12,15-tetraoxa-3,18-diazaicosanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)py N'-(5-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-oxo-4,5-dihydro-1,3,5-triazin-2-yl)-N,N-dimethylformimidamide
CAS:183016-17-3
Formula: C11H17N5O4
98%
183016-17-3
Methanimidamide, N'-[5-(2-deoxy-+¦-D-erythro-pentofuranosyl)-4,5-dihydro-4-oxo-1,3,5-triazin-2-yl]-N,N-dimethyl-; N'-(5-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-oxo-4,5-dihydro-1,3,5-Triazine-2-yl)-N,N-dimethylformamide N'-(5-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-4-oxo-4,5-dihydro-1,3,5-triazin-2-yl)-N,N-dimethylformimidamide
CAS:2304649-45-2
Formula: C32H35N5O6
98%
2304649-45-2
Methanimidamide, N'-[5-[5-O-[bis(4-methoxyphenyl)phenylmethyl]-2-deoxy-+¦-D-erythro-pentofuranosyl]-5,6-dihydro-6-oxo-1,3,5-triazin-2-yl]-N,N-dimethyl-; N'-[5-[5-O-[Bis(4-methoxyphenyl)phenylmethyl]-2-deoxy-+¦-D-erythro-pentofuranosyl]-5,6-di N'-(5-CHLOROPYRIDIN-2-YL)-N-[(1R,2R,4R)-4-(DIMETHYLCARBAMOYL)-2-[(5-METHYL-6,7-DIHYDRO-4H-[1,3]THIAZOLO[5,4-C]PYRIDINE-2-CARBONYL)AMINO]CYCLOHEXYL]OXAMIDE
CAS:1255529-24-8
Formula: C24H30ClN7O4S
97.0%
B2694-480568
Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1R,2R,4R)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-; N1-(5-Chloro-2-pyridinyl)-N2-[(1R,2R,4R)-4-[(dimethylamino)carbonyl N'-(5-Chloropyridin-2-yl)-N-[(1R,2R,4R)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide tosylate
CAS:2852734-46-2
Formula: C24H30ClN7O4S.C7H8O3S
>95%
2852734-46-2
Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1R,2R,4R)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-, compd. with 4-methylbenzenesulfonate (1:1); N1-(5-Chloropyridin-2-y N'-[(3-INDOLYL)METHYLENE]-2-[(3,5-DIOXO-2,3,4,5-TETRAHYDRO-1,2,4-TRIAZIN-6-YL)AMINO]ACETOHYDRAZIDE
CAS:307508-65-2
Formula: C14H13N7O3
BB020708
2-[(3,5-dioxo-2H-1,2,4-triazin-6-yl)amino]-N-(1H-indol-3-ylmethylideneamino)acetamide; 2-[(3,5-dioxo-2H-1,2,4-triazin-6-yl)amino]-N-(1H-indol-3-ylmethylideneamino)acetamide N'-[(3-INDOLYL)METHYLENE]-3-[(3,5-DIOXO-2,3,4,5-TETRAHYDRO-1,2,4-TRIAZIN-6-YL)AMINO]PROPANEHYDRAZIDE
CAS:307508-66-3
Formula: C15H15N7O3
BB020709
3-[(3,5-dioxo-2H-1,2,4-triazin-6-yl)amino]-N-(1H-indol-3-ylmethylideneamino)propanamide; 3-[(3,5-dioxo-2H-1,2,4-triazin-6-yl)amino]-N-(1H-indol-3-ylmethylideneamino)propanamide |
